Great Bay Bio injected with 2.5 million USD of convertible note
Summary
[2020.01.06-Dongguan] Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing shareholders, which including renowned financial institute and family foundation. Such injection of funds fully shows the confidence and support by existing shareholders to Great Bay Bio for its results in 2019. Capital will be injected into projects, to further optimize CMC service platform and product pipeline development of Great Bay Bio. Since 2006, it has undertaken a number of government projects and obtained crucial breakthroughs in key areas of Guangdong and Hong Kong. More than 20 million yuan have been received from the government to support numerous provincial and national projects, such as "National Major New Drug Innovation" The CMC platform encompasses an area of over 3100 square meter, and has a whole set of advanced biopharmaceutical research and development hardware, with key equipment from world-class brands such as Sartorius, Bio-Rad, GE Healthcare, and Waters.